Markus Zwick

Markus Zwick, PhD has a diverse work experience spanning various roles and companies. Markus is currently a Manager in QC at Bavarian Nordic, a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines. In this role, Markus is responsible for construct specific release testing of clinical trial material and commercial products under GMP quality standards. Prior to their current position, they served as a Coordinating Scientist and Scientist in QC at Bavarian Nordic.

Before joining Bavarian Nordic, Markus worked as a PhD student at Ludwig-Maximilians Universität München from December 2011 to June 2017. Markus also completed a Master's thesis at Friedrich-Alexander-Universität Erlangen-Nürnberg from November 2010 to May 2011. Additionally, they gained experience as a Student Assistant at the same university from July 2009 to July 2010.

Overall, Markus Zwick, PhD has a strong background in quality control and research in the biotechnology industry, with a focus on vaccine development and clinical trial testing.

Markus Zwick, Ph.D., completed their education in a chronological order. Starting in 2005, they earned their Bachelor of Science (B.Sc.) degree in Biology, with a focus on general biology, from FAU Erlangen-Nürnberg. Markus continued their studies and obtained a Master of Science (M.Sc.) degree in Cellular Biology and Molecular Biology from the same institution between 2009 and 2011. Markus further pursued their academic journey at Ludwig-Maximilians-Universität München, where they completed their Ph.D. in Immunology from 2011 to 2017.